MoneyWorks4Me

Dr. Reddy’s Laboratories informs about newspaper advertisement

31 Oct 2022 Evaluate

Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015, as amended, Dr. Reddy’s Laboratories has informed enclosed copies of newspaper advertisement regarding the unaudited financial results of the company for the quarter and half-year ended September 30, 2022, as published in Financial Express and Andhra Prabha on October 30, 2022.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1149.00
Cipla 1354.50
Lupin 2061.20
Zydus Lifesciences 1105.00
View more..